- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02433743
Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA (PLWHA)
Daily Consumption of Ready-to-use Peanut-based Therapeutic Food Increased Fat Free Mass, Improved Anemia Status But Has no Impact on Zinc Status of People Living With HIV/AIDS (PLWHA)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The sample size of the study (n=17 in each group) was calculated takin into account the mean gain of fat free mass (2.3± 2.1 kg) obtained in a study of PLWH supplemented with 43 g of RUTF/day. The randomization was performed upon admission using a computer-generated random number list (EPI INFO 6.0; Centers for Disease Control and Prevention, Atlanta).
Dietary intakes were measured during 7 consecutive days in 10 subjects of each group during the hospitalization period. Each meal served was weighed with a food scale (i-Balance 2600 Myweigh, Phoenix, USA).
Anthropometrics measurement was performed using standard procedures. Measure of height was made using height board (SECA 216, GmbH et Co, Hamburg, Germany), to the nearest millimeter. Body weight was measured with an electronic scale (SECA 877, GmbH & Co, Hamburg, Germany).
Body composition was measured using a multifrequency analyser, Xitron 4000B. The accuracy of the instrument was tested before the measurements by using a 422 ohm standard resistor purchased with the analyzer. Blood sampling was performed in the morning between 8 -10 AM into trace element-free polyethylene tubes zinc-free containing lithium heparin anticoagulant. The time of the sample collection and of the most recent food or milk intake were noted and used to adjust for this interval in the analysis of data. All the parameters were mesured in duplicate on admission, at 3 weeks and 9 weeks home based follup up.
Double entry data, and quality control of the entry were performed using Epi-Info version 3.5.1 (CDC, Atlanta, USA) and access. Statistical analysis was performed by Excel 2003 (Microsoft Corporation, Redmond, USA) and STATA / SE 11.0 (Stata Corporation, Texas, and USA). Results are expressed as mean ± standard deviation and percentage. PZ concentration was adjusted for the time interval between the last meal and the blood drawing to minimize the variability due to the known meal-related effects on PZ concentration and from infections/inflammation [28]. Zinc deficiency was defined according to IZINCG cut-off. ANOVA followed by post-hoc Bonferroni tests for pairwise comparison of means or Student's t-test were also used on dependent measures. The Pearson Chi2 test or Fisher's exact test were used to compare percentages. P values 0.05 were considered as significant.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Dakar, Senegal
- University Cheikh Anta Diop
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- HIV/AIDS men and women
- at any WHO stages of HIV disease,
- under ART treatment or not,
- without psychiatric illness and not diabetic
Exclusion Criteria:
- confirmed HIV-negative,
- long term physical disability
- inability to eat
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control
Control group (n=33) didn't received intervention.
The received the standard hospital diet
|
|
Experimental: Ready-to-use therapeutic food (RUTF)
RUTF group (n=32) received the standard hospital diet combined with 100 g/day of RUTF
|
HIV-infected patients were randomly allocated to receive standard hospital diet (Control: n=33), or this diet combined with 100 g/day of RUTF (RUTF: n=32).
All patients was follow-up during hospitalisation and 9 week after discharge at home
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in body composition at 9 weeks
Time Frame: 9 weeks
|
Body composition was measured using Bio-impedance analysis method at baseline, and 9 weeks home-based follow-up in both supplemented and control groups
|
9 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline on anemia at 3 weeks
Time Frame: 3 weeks
|
Hemoglobin was measured by Hemocue photometer at baseline and 3 week after admission in both supplemented and control groups
|
3 weeks
|
Change from baseline on anemia at 9 weeks
Time Frame: 9 weeks
|
Hemoglobin was measured by Hemocue photometer at baseline and after 9 weeks home-based follow-up in both supplemented and control groups
|
9 weeks
|
Change from baseline on plasma zinc concentration at 3 weeks
Time Frame: 3 weeks
|
Plasma zinc concentration was determined by Atomic absorption spectrometry at baseline and 3 weeks after admission in both supplemented and control groups
|
3 weeks
|
Change from baseline on plasma zinc concentration at 9 weeks
Time Frame: 9 weeks
|
Plasma zinc concentration was determined by Atomic absorption spectrometry at baseline and after 9 weeks home-based follow-up in both supplemented and control groups
|
9 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Salimata Wade, Professor, Université Cheikh Anta Diop de Dakar
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Hematologic Diseases
- Nutrition Disorders
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
- Anemia
- Malnutrition
Other Study ID Numbers
- UCheikhAntaDiop
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malnutrition
-
HAN University of Applied SciencesFrieslandCampina; HAS Hogeschool; Centre of Expertise Food (CoE Food); SligroCompletedMalnutrition; Protein | Protein MalnutritionNetherlands
-
International Centre for Diarrhoeal Disease Research...GlaxoSmithKline; Stanford UniversityCompletedMalnutrition | Malnutrition in Children | Child MalnutritionBangladesh
-
University of Nove de JulhoUnknownMalnutrition, ChildBrazil
-
UNICEFSave the ChildrenCompletedSevere MalnutritionCongo, The Democratic Republic of the
-
International Centre for Diarrhoeal Disease Research...UNICEFNot yet recruitingMalnutrition SevereBangladesh
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition | Severe Acute Malnutrition
-
Academy of Nutrition and DieteticsHartford Hospital; University of New Mexico; Meals on Wheels Central TexasNot yet recruiting
-
Diego MorettiSwiss Federal Institute of Technology; Wageningen University and Research; St... and other collaboratorsCompletedMalnutrition; ProteinSwitzerland
-
International Centre for Diarrhoeal Disease Research...CompletedProtein MalnutritionBangladesh
-
Microbiome Health Research InstituteUniversity of Cape TownTerminatedModerate Acute Malnutrition | Severe Acute MalnutritionSouth Africa
Clinical Trials on Ready-to-use therapeutic food (RUTF)
-
UNICEF - VenezuelaTerminatedWasting | Acute Malnutrition in Childhood | Child MalnutritionVenezuela
-
Infectious Diseases InstituteUniversity of Dublin, Trinity CollegeUnknown
-
International Rescue CommitteeMinistry of health, Mali; University of the Sciences, Techniques and Technologies...Active, not recruitingAcute Malnutrition in Childhood | Underweight | Acute Malnutrition in InfancyMali
-
Alliance for International Medical ActionInstitut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaboratorsCompletedGlobal Acute Malnutrition (GAM)Burkina Faso
-
International Centre for Diarrhoeal Disease Research...Washington University School of MedicineNot yet recruitingSevere Acute MalnutritionBangladesh
-
Medecins Sans Frontieres, NetherlandsCompletedWeight Loss | Malaria | Weight Gain | ConvalescenceCongo
-
Institut de Recherche en Sciences de la Sante,...Bill and Melinda Gates Foundation; Ministry of Health, Burkina FasoNot yet recruitingAcute Malnutrition With no ComplicationsBurkina Faso
-
Aga Khan UniversityUnited Nations World Food Programme (WFP); People's Primary Healthcare Initiative...WithdrawnSevere Acute MalnutritionPakistan
-
Action Against Hunger USAUniversity of Washington; Ethiopian Public Health InstituteNot yet recruitingModerate Acute Malnutrition
-
Washington University School of MedicineUniversity of MalawiCompleted